The Korea Journal of Herbology (대한본초학회지)

The Korea Association of Herbology (대한본초학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-fibrotic Effect of Mori Folium Extract in Hepatic Stellate Cells

간성상세포에서 상엽(桑葉) 추출물의 섬유화 억제 효과

  • 변성희 (대구한의대학교 한의과대학) ;
  • 박상미 (대구한의대학교 한의과대학) ;
  • 김상찬 (대구한의대학교 한의과대학) ;
  • 조일제 (대구한의대학교 한의과대학)
  • Received : 2013.06.19
  • Accepted : 2013.07.18
  • Published : 2013.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Mori Folium was popularly used as one of the traditional medicinal herbs. Although M. Folium has been cultivated for rearing silkworm historically, it's use has been expanded as natural therapeutic agent for the treatment of filariasis, diabetes and dropsy in East Asia. However, little has been known about the effect of M. Folium on liver fibrosis. Therefore, we would like to explore an anti-fibrogenic potential of M. Folium extract (MFE) using immortalized human hepatic stellate cell line, LX-2 cells. Methods : We examined the effects of MFE on the transforming growth factor ${\beta}1$ ($TGF{\beta}1$)-induced liver fibrosis in LX-2 cells. Cell viability, Smad binding element-driven luciferase activity, phosphorylations level of Smad 2/3, and expression level of $TGF{\beta}1$-dependent target genes were monitored in the MFE-treated LX-2 cells. Results : Up to 30 ${\mu}g/ml$ MFE treatment did not show any possible toxic effect in LX-2 cells. MFE inhibited $TGF{\beta}1$-inducible Smad binding element-driven luciferase activity and decreased the $TGF{\beta}1$-inducible phosphorylations of Smad 2 and Smad 3 in hepatic stellate cell in a dose dependent manner. Furthermore, increases of plasminogen activator inhibitor type 1, $TGF{\beta}1$ and matrix metalloproteinases 2 genes by $TGF{\beta}1$ were also attenuated by MFE treatment. Conclusions : These findings suggested that MFE would be used as a potential therapeutic agent for the treatment liver fibrosis, which might be mediated by the inhibition of $TGF{\beta}1$-inducible Smad 2/3 transactivation and target genes expression.

Keywords

References

  1. Bataller B, Brenner DA. Hepatic Fibrosis. In : Arias IM, Alter HJ, Boyer JL, Cohen DE, Fausto N, Shafritz DA, Wolkoff AW, eds. The liver biology and pathobiology. 5th ed. Oxford : Wiley-Blackwell. 2009 : 433-52.
  2. Lee JS, Kim JH. The role of activated hepatic stellate cells in liver fibrosis, portal hypertension and cancer angiogenesis. Korean J Hepatol. 2007 ; 13 : 309-19. https://doi.org/10.3350/kjhep.2007.13.3.309
  3. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor b1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA. 1995 ; 92 : 2572-6. https://doi.org/10.1073/pnas.92.7.2572
  4. Liu C, Gaca MD, Swenson E, Vellucci VF, Reiss M, Wells RG. Smads 2 and 3 are differentially activated by transforming growth factor-$\beta$ (TGF-$\beta$) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-$\beta$ independent. J Biol Chem. 2003 ; 278 : 11721-8. https://doi.org/10.1074/jbc.M207728200
  5. Jablonska E, Markart P, Zakrzewicz D, Preissner KT, Wygrecka M. Transforming growth factor-$\beta1$ induces expression of human coagulation factor XII via Smad3 and JNK signaling pathways in human lung fibroblasts. J Biol Chem. 2010 ; 285 : 11638-51. https://doi.org/10.1074/jbc.M109.045963
  6. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF$\beta$-inducible elements in the promoter of human plasminogen activator inhibitortype 1 gene. EMBO J. 1998 ; 17 : 3091-100. https://doi.org/10.1093/emboj/17.11.3091
  7. Cho IJ, Kim SH, Kim SG. Inhibition of $TGF\beta1$-mediated PAI-1 induction by oltipraz through selective interruption of Smad 3 activation. Cytokines. 2006 ; 35 : 284-94. https://doi.org/10.1016/j.cyto.2006.10.001
  8. Cho IJ, Kim YW, Han CY, Kim EH, Anderson RA, Lee YS, Lee CH, Hwang SJ, Kim SG. E-cadherin antagonizes transforming growth factor $\beta1$ gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation. Hepatology. 2010 ; 52 : 2053-64. https://doi.org/10.1002/hep.23931
  9. The Korean Medical Dictionary Compliation Committee. The Korean Medical Dictionary. Seoul : Jungdam. 1998 : 727.
  10. Park SM, Byun SH, Kim YW, Cho IJ, Kim SC. Inhibitory effect of Mori Folium ethanol extract on pro-inflammatory mediator in lipopolysaccharide-activated RAW 264.7 cells. Kor J Herbology. 2012 ; 27 : 31-8. https://doi.org/10.6116/kjh.2012.27.3.31
  11. Jang MH, Kim H, Shin MC, Lim BV, Lee TH, Jung SB, Kim CJ, Kim EH. Administration of Folium Mori extract decreases nitric oxide synthase expression in the hypothalamus of streptozotocininduced diabetic rats. Jpn J Pharmacol. 2002 ; 90 : 189-92. https://doi.org/10.1254/jjp.90.189
  12. Sugimoto M, Arai H, Tamura Y, Murayama T, Khaengkhan P, Nishio T, Ono K, Ariyasu H, Akamizu T, Ueda Y, Kita T, Harada S, Kamei K, Yokode M. Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adipose tissue in b/db mice. Atherosclerosis. 2009 ; 204 : 388–94. https://doi.org/10.1016/j.atherosclerosis.2008.10.021
  13. Harauma A, Murayama T, Ikeyama K, Sano H, Arai H, Takano R, Kita T, Hara S, Kamei K, Yokode M. Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2007 ; 358 : 751-6. https://doi.org/10.1016/j.bbrc.2007.04.170
  14. Sattayasai J, Tiamkao S, Puapairoj P. Biphasic effects of Morus alba leaves green tea extract on mice in chronic forced swimming model. Phytother Res. 2008 ; 22 : 487-92. https://doi.org/10.1002/ptr.2346
  15. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P, Gressner AM. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGF beta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 2001 ; 502 : 4-10. https://doi.org/10.1016/S0014-5793(01)02656-4
  16. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem. 2001 ; 276 : 19945-53. https://doi.org/10.1074/jbc.M102382200
  17. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev. 2000 ; 14 : 627-44.
  18. Liu X, Wang W, Hu H, Tang N, Zhang C, Liang W, Wang M. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells. Pharm Res. 2006 ; 23 : 82-9. https://doi.org/10.1007/s11095-005-9043-5
  19. Kang KW, Kim YG, Cho MK, Bae SK, Kim CW, Lee MG, Kim SG. Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation. FASEB J. 2002 ; 16 : 1988–90.
  20. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 2003 ; 125 : 178-91. https://doi.org/10.1016/S0016-5085(03)00666-8
  21. Inagaki Y, Mamura M, Kanamaru Y, Greenwel P, Nemoto T, Takehara K, Ten Dijke P, Nakao A. Constitutive phosphorylation and nuclear localization of Smad 3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol. 2001 ; 187 : 117-23. https://doi.org/10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S
  22. Doi K, Kojima T, Makino M, Kimura Y, Fujimoto Y. Studies on the constituents of the leaves of Morus alba L. Chem Pharm Bull (Tokyo). 2001 ; 49 : 151-3. https://doi.org/10.1248/cpb.49.151
  23. Hernandez-Ortega LD, Alcantar-Diaz BE, Ruiz-Corro LA, Sandoval-Rodriguez A, Bueno-Topete M, Armendariz-Borunda J, Salazar-Montes AM. Quercetin improves hepatic fibrosis reducing hepatic stellate cells and regulating pro-fibrogenic/anti-fibrogenic molecules balance. J Gastroenterol Hepatol. 2012 ; 27 : 1865-72. https://doi.org/10.1111/j.1440-1746.2012.07262.x
  24. Marcolin E, San-Miguel B, Vallejo D, Tieppo J, Marroni N, Gonzalez-Gallego J, Tunon MJ. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J Nutr. 2012 ; 142 : 1821-8. https://doi.org/10.3945/jn.112.165274
  25. Kanter M. Protective effect of quercetin on liver damage induced by biliary obstruction in rats. J Mol Histol. 2010 ; 41 : 395-402. https://doi.org/10.1007/s10735-010-9301-7
  26. Lee HS, Jung KH, Park IS, Kwon SW, Lee DH, Hong SS. Protective effect of morin on dimethylnitrosamine-induced hepatic fibrosis in rats. Dig Dis Sci. 2009 ; 54 : 782-8. https://doi.org/10.1007/s10620-008-0404-x